Figure 4
From: NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
Kaplan-Meier analysis of OS rates in patients with or without NQO1 expressed NSCLC in prognostic factors. OS was assessed in NSCLC patients with T1-2 (A, P = 0.002), T3-4 (B, P = 0.002), LN metastasis (−) (C, P = 0.002), LN metastasis (+) (D, P = 0.553), I-II stage (E, P = 0.016), and III-IV stage (F, P = 0.050) concomitant with either positive- or negative-expression of NQO1.